Thiamine is a key component in the creation of physiologic anti-inflammatory mediators. Serum
thiamine stores have been found to be deficient in diabetic patients. Thiamine deficiency may
be a key pathological mechanism of inflammation that results in diabetic kidney and retinal
injury. The investigators hypothesize that the repletion of a patient's thiamine by oral
supplementation may result in reduced inflammation, and therefore reduced kidney injury.